Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.9%

2 terminated out of 51 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

26%

9 of 34 completed with results

Key Signals

9 with results94% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (6)
P 1 (39)
P 2 (1)
P 3 (3)

Trial Status

Completed34
Recruiting7
Unknown3
Not Yet Recruiting3
Terminated2
Active Not Recruiting1

Trial Success Rate

94.4%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT07016802Phase 1Recruiting

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

NCT06633562Phase 1Active Not Recruiting

A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

NCT07286656Phase 1Recruiting

A Study of GensSci098 in Subjects With Graves' Disease

NCT06569758Phase 1Recruiting

A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

NCT06243354Phase 1Recruiting

Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation

NCT06639256Phase 1Recruiting

Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

NCT07285967Phase 1Not Yet Recruiting

A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet

NCT06770491Phase 1Completed

A Phase 1 Study of Y-3 in US Healthy Volunteers.

NCT06752122Phase 1Recruiting

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

NCT05142592Phase 1Recruiting

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

NCT06380270Not ApplicableCompleted

Evaluation of Safety and Human Tolerance of Oral Probiotic Streptococcus Salivarius eK12

NCT04693429Phase 1Completed

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

NCT06847698Phase 1Not Yet Recruiting

Single Ascending Dose and Multiple Ascending Dose Study of AVR-48

NCT05556291Completed

Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study

NCT06879067Phase 1Completed

Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers

NCT05143905Phase 1Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

NCT05633147Phase 1Completed

Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam

NCT06539091Phase 3Not Yet Recruiting

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

NCT04691115Phase 1Completed

Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects

NCT05795192Phase 1Completed

SB17170 Phase1 Trial in Healthy Volunteer

Scroll to load more

Research Network

Activity Timeline